cyproterone acetate has been researched along with Drug Withdrawal Symptoms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baniel, J; Flex, D; Sella, A; Sulkes, A | 1 |
| Christiansen, C; Jensen, J; Riis, BJ; Strøm, V | 1 |
| Christiansen, C; Johansen, JS; Riis, BJ; Rødbro, P; Thomsen, K | 1 |
3 trial(s) available for cyproterone acetate and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Antiandrogen withdrawal syndrome with cyproterone acetate.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Humans; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome | 1998 |
Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation; Substance Withdrawal Syndrome; Time Factors | 1989 |
Bone turnover in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcium-Binding Proteins; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Female; Humans; Hydroxyproline; Menopause; Middle Aged; Osteocalcin; Osteoporosis; Progesterone; Substance Withdrawal Syndrome | 1987 |